PLG and obesity disorder: This hypothesis has been proven positive in mice with the inhibitors endostatin, angiostatin, VEGFR2 and TNP-470 displaying the ability to reduce body weight or prevent the development of obesity in subjects prone to excessive weight gain [32,33,34].